Your browser doesn't support javascript.
loading
The effects of intrathecal rituximab on biomarkers in multiple sclerosis.
Topping, Joanne; Dobson, Ruth; Lapin, Sergey; Maslyanskiy, Alexey; Kropshofer, Harald; Leppert, David; Giovannoni, Gavin; Evdoshenko, Evgeniy.
Afiliação
  • Topping J; Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England.
  • Dobson R; Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England. Electronic address: ruth.dobson@qmul.ac.uk.
  • Lapin S; First Pavlov State Medical University, Center for Molecular Medicine, Laboratory of Autoimmune Diagnostics, 6/8 Leo Tolstoy St, 197022 Saint Petersburg, Russia.
  • Maslyanskiy A; Federal Almazov Medical Research Centre, Saint Petersburg, Russia.
  • Kropshofer H; F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Grenzacherstrasse, Basel, Switzerland.
  • Leppert D; F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Grenzacherstrasse, Basel, Switzerland.
  • Giovannoni G; Blizard Institute, Queen Mary University, 4 Newark Street, London E1 2AT, England.
  • Evdoshenko E; MS Center (City Clinical Hospital 31), Saint Petersburg, Russia.
Mult Scler Relat Disord ; 6: 49-53, 2016 Mar.
Article em En | MEDLINE | ID: mdl-27063622
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente / Rituximab / Fatores Imunológicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Crônica Progressiva / Esclerose Múltipla Recidivante-Remitente / Rituximab / Fatores Imunológicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article